APA (7th ed.) Citation

Venegas-Rodríguez, R., Serrano-Díaz, A., Peña-Ruiz, R., Santana-Sánchez, R., Hernández-Cedeño, M., Rittoles Navarro, A., . . . Domínguez- Horta, M. d. C. (2023). Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study. PLoS ONE, 18(2), 1. https://doi.org/10.1371/journal.pone.0281111

Chicago Style (17th ed.) Citation

Venegas-Rodríguez, Rafael, et al. "Jusvinza, an Anti-inflammatory Drug Derived from the Human Heat-shock Protein 60, for Critically Ill COVID-19 Patients. An Observational Study." PLoS ONE 18, no. 2 (2023): 1. https://doi.org/10.1371/journal.pone.0281111.

MLA (9th ed.) Citation

Venegas-Rodríguez, Rafael, et al. "Jusvinza, an Anti-inflammatory Drug Derived from the Human Heat-shock Protein 60, for Critically Ill COVID-19 Patients. An Observational Study." PLoS ONE, vol. 18, no. 2, 2023, p. 1, https://doi.org/10.1371/journal.pone.0281111.